TRINA GOMM: Open Payments
NPI 1356594022 · SAFFORD, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$384 in 21 payments from 9 companies in 2025. Trend: 2023 $554 · 2024 $618 · 2025 $384
Food & beverage: $384
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $135 |
| Amgen Inc. | 4 | $73 |
| PFIZER INC. | 2 | $35 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $33 |
| Insulet Corporation | 1 | $29 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $29 |
| Novo Nordisk Inc | 1 | $19 |
| Lilly USA, LLC | 1 | $17 |
| Astellas Pharma US Inc | 1 | $14 |
Products named: AIRSUPRA, EVENITY, NURTEC ODT, XIFAXAN, Omnipod, Kerendia, FARXIGA, Rybelsus.
Industry payments across AZ — which companies pay providers there.
